INFINITY PHARMACEUTICALS INC's ticker is and the CUSIP is 45665G903. A total of 4 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $8,336 | +28.3% | 39,600 | -2.5% | 0.00% | – |
Q1 2023 | $6,496 | -71.2% | 40,600 | -0.2% | 0.00% | – |
Q4 2022 | $22,588 | -74.9% | 40,700 | -45.9% | 0.00% | – |
Q3 2022 | $90,000 | +100.0% | 75,300 | +5.0% | 0.00% | – |
Q2 2022 | $45,000 | -64.8% | 71,700 | -36.2% | 0.00% | – |
Q1 2022 | $128,000 | -62.5% | 112,300 | -25.9% | 0.00% | – |
Q4 2021 | $341,000 | -53.9% | 151,600 | -29.8% | 0.00% | -100.0% |
Q3 2021 | $739,000 | +139.2% | 216,100 | +109.4% | 0.00% | – |
Q2 2021 | $309,000 | -39.9% | 103,200 | -35.2% | 0.00% | -100.0% |
Q1 2021 | $514,000 | +1558.1% | 159,200 | +983.0% | 0.00% | – |
Q4 2020 | $31,000 | -26.2% | 14,700 | -59.1% | 0.00% | – |
Q3 2020 | $42,000 | +950.0% | 35,900 | +775.6% | 0.00% | – |
Q2 2020 | $4,000 | +33.3% | 4,100 | +2.5% | 0.00% | – |
Q1 2020 | $3,000 | -91.2% | 4,000 | -88.7% | 0.00% | – |
Q4 2019 | $34,000 | +142.9% | 35,300 | +163.4% | 0.00% | – |
Q3 2019 | $14,000 | -68.2% | 13,400 | -45.7% | 0.00% | – |
Q2 2019 | $44,000 | -25.4% | 24,700 | -21.6% | 0.00% | -100.0% |
Q1 2019 | $59,000 | +59.5% | 31,500 | +0.6% | 0.00% | – |
Q4 2018 | $37,000 | -78.2% | 31,300 | -50.1% | 0.00% | -100.0% |
Q3 2018 | $170,000 | -26.1% | 62,700 | -47.8% | 0.00% | -50.0% |
Q2 2018 | $230,000 | +69.1% | 120,200 | +86.1% | 0.00% | +100.0% |
Q1 2018 | $136,000 | -33.7% | 64,600 | -36.0% | 0.00% | 0.0% |
Q4 2017 | $205,000 | +2177.8% | 100,900 | +1341.4% | 0.00% | – |
Q3 2017 | $9,000 | -94.6% | 7,000 | -93.5% | 0.00% | -100.0% |
Q2 2017 | $168,000 | -36.6% | 106,900 | +30.2% | 0.00% | -33.3% |
Q1 2017 | $265,000 | +8733.3% | 82,100 | +3184.0% | 0.00% | – |
Q4 2016 | $3,000 | -87.5% | 2,500 | -84.1% | 0.00% | – |
Q3 2016 | $24,000 | +41.2% | 15,700 | +375.8% | 0.00% | – |
Q1 2016 | $17,000 | +54.5% | 3,300 | +135.7% | 0.00% | – |
Q4 2015 | $11,000 | -96.6% | 1,400 | -96.3% | 0.00% | -100.0% |
Q3 2015 | $320,000 | +966.7% | 37,900 | +1303.7% | 0.00% | – |
Q2 2015 | $30,000 | -77.9% | 2,700 | -72.2% | 0.00% | -100.0% |
Q1 2015 | $136,000 | -86.6% | 9,700 | -83.8% | 0.00% | -86.7% |
Q4 2014 | $1,013,000 | -18.6% | 60,000 | -35.3% | 0.02% | -21.1% |
Q3 2014 | $1,244,000 | +38.1% | 92,700 | +31.1% | 0.02% | +35.7% |
Q2 2014 | $901,000 | +28.9% | 70,700 | +20.2% | 0.01% | +16.7% |
Q1 2014 | $699,000 | -58.6% | 58,800 | -51.9% | 0.01% | -52.0% |
Q4 2013 | $1,688,000 | +25.3% | 122,200 | +58.3% | 0.02% | -3.8% |
Q3 2013 | $1,347,000 | -55.6% | 77,200 | -58.7% | 0.03% | -65.3% |
Q2 2013 | $3,037,000 | – | 186,900 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 186,900 | $3,037,000 | 0.08% |
SABBY MANAGEMENT, LLC | 666 | $1,082,000 | 0.07% |
Citadel Advisors | 12,900 | $210,000 | 0.00% |